Home/Filings/4/0001628280-25-033513
4//SEC Filing

Hoppenot Herve 4

Accession 0001628280-25-033513

CIK 0000879169other

Filed

Jun 29, 8:00 PM ET

Accepted

Jun 30, 4:32 PM ET

Size

10.1 KB

Accession

0001628280-25-033513

Insider Transaction Report

Form 4
Period: 2025-06-26
Hoppenot Herve
DirectorChief Executive OfficerOther
Transactions
  • Award

    Performance Shares

    2025-06-26+18,05018,050 total
    Exp: 2028-06-26Common Stock (18,050 underlying)
  • Award

    Common Stock

    2025-06-26+6,016569,589 total
  • Award

    Employee Stock Option (right to buy)

    2025-06-26+18,43818,438 total
    Exercise: $70.81Exp: 2035-06-25Common Stock (18,438 underlying)
Footnotes (4)
  • [F1]Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.
  • [F2]Including the June 26, 2025 grant, this includes an aggregate of 187,611 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested.
  • [F3]The June 26, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
  • [F4]Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ('TSR') over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date.

Issuer

INCYTE CORP

CIK 0000879169

Entity typeother

Related Parties

1
  • filerCIK 0001596492

Filing Metadata

Form type
4
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:32 PM ET
Size
10.1 KB